Table 2.
IC50 values (µM) of novel thiazolinylphenyl-piperazines (2a–c; 3a-c) observed on breast and prostate cancer cell lines.
| Compd. | MCF-7 | SKBR-3 | MDA-MB231 | LNCAP | DU-145 | PC-3 |
|---|---|---|---|---|---|---|
| 2a | 14.7 ± 1.9 | 28.17 ± 4.1 | 31.37 ± 5.1 | 67.24 ± 13.1 | 66.63 ± 7.3 | - |
| 2b | 15.93 ± 1.8 | 27.58 ± 5.6 | 39.96 ± 9.8 | 48.48 ± 7.3 | 66.58 ± 9.4 | - |
| 2c | 19.47 ± 2.3 | 27.65 ± 4.8 | 36.32 ± 7.7 | 31.93 ± 9.2 | 47.74 ± 11.7 | - |
| 3a | - | - | 23.27 ± 3.4 | - | - | 73.3 ± 10.3 |
| 3b | - | - | 34.6 ± 5.4 | - | - | 64.96 ± 7.4 |
| 3c | - | - | 47.15 ± 6.7 | - | - | 32.09 ± 10.2 |